1. Home
  2. AXIL vs MDAI Comparison

AXIL vs MDAI Comparison

Compare AXIL & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AXIL Brands Inc.

AXIL

AXIL Brands Inc.

N/A

Current Price

$7.00

Market Cap

38.6M

ML Signal

N/A

MDAI

Spectral AI Inc.

N/A

Current Price

$1.65

Market Cap

39.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AXIL
MDAI
Founded
2015
2013
Country
United States
United States
Employees
N/A
78
Industry
Package Goods/Cosmetics
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.6M
39.6M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
AXIL
MDAI
Price
$7.00
$1.65
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$3.25
AVG Volume (30 Days)
9.6K
518.3K
Earning Date
04-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.13
N/A
Revenue
$26,257,522.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$44.69
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.04
$1.04
52 Week High
$10.25
$3.21

Technical Indicators

Market Signals
Indicator
AXIL
MDAI
Relative Strength Index (RSI) 61.06 61.00
Support Level $4.76 $1.48
Resistance Level $7.16 $1.76
Average True Range (ATR) 0.45 0.12
MACD 0.11 0.04
Stochastic Oscillator 97.30 81.74

Price Performance

Historical Comparison
AXIL
MDAI

About AXIL AXIL Brands Inc.

AXIL Brands Inc is a company which is is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, and outdoor speakers, under the AXIL brand. AXIL delivers top hearing enhancement, protection, & audio devices. From ultra comfortable fitting processes, to stereo quality sound performance, to reliable & durable engineering. The company operates two operating segments: hearing enhancement and protection, and hair and skin care.

About MDAI Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Share on Social Networks: